Caldwell, IV discussed key elements on extension of human longevity at 7th Insurance Linked Securities Summit

Advanced Cell Technology, Inc. (OTCBB: ACTC), a biotechnology company applying cellular technology in the field of regenerative medicine, announced today that company Chairman and Chief Executive Officer, William M. Caldwell, IV, will be delivering a luncheon keynote address today at the 7^th Insurance Linked Securities Summit, being held January 27-29, 2010 at the Roosevelt Hotel in New York City. This annual gathering brings together the entire value chain for both the life and non-life markets, including institutional investors, hedge funds, insurance and reinsurance companies, life insurance settlement providers, underwriters, law firms, and banks. Mr. Caldwell will be delivering a presentation titled, "The Evolving Parameters of Human Longevity: Biotech Perspectives on the Ability of Medical Technology to Enhance the Human Lifespan." Mr. Caldwell is expected to discuss key elements in the extension of human longevity thus far, and specifically the impact that the field of Regenerative Medicine and the Company's technology platform will have on extending quality of life in the future.

“The Evolving Parameters of Human Longevity: Biotech Perspectives on the Ability of Medical Technology to Enhance the Human Lifespan.”

In addition to Advanced Cell Technology, other participating organizations at the 7^th ILS Summit include the World Bank Treasury, TIAA-CREF, Allianz, the London School of Economics, Harvard University, Kappa Life and New York State Senator Neil Breslin.

http://www.ilsnewyork.com.